European Companies Search Engine
Merger: BioNTech RNA Pharmaceuticals GmbH Hrb22 Jun 2021 German Trade Register Announcements, Germany
Text
HRB 48720: BioNTech SE,
Mainz, An der Goldgrube 12, 55131 Mainz
. As an acquiring legal entity, the company has merged with the BioNTech RNA Pharmaceuticals GmbH with its registered office in Mainz (HRB 42030) in accordance with the merger agreement of 15 April 2021 (merger by admission). As not registered is made known: If the creditors of the companies participating in the merger are deemed to have been made public in writing within six months of the date on which the entry of the merger in the register of the registered office of the legal entity of which they are creditors are deemed to have been made public pursuant to § 19 paragraph 3 UmwG, they must file their claim in advance of the reason and amount, insofar a.s. they cannot demand satisfaction. However, creditors only have this right if they make it credible that the merger jeopardises the fulfilment of their claim.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: BioNTech SE, Mainz, Germany.